SCHEMBL5508145

SCHEMBL5508145

Cc1cc(N2COc3cc(F)c(F)cc3C2=O)ccc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.47
ALDH1A1 P00352 4/20 0.38
MAPT P10636 7/20 0.38
KDM4E B2RXH2 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
POLB P06746 1/20 0.36
PKM P14618 1/20 0.36
GFER P55789 1/20 0.36
MCL1 Q07820 1/20 0.36
GPR55 Q9Y2T6 1/20 0.36
SIRT6 Q8N6T7 2/20 0.35
ADAMTS5 Q9UNA0 1/20 0.34
TSHR P16473 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5999601 0.90 HPGD (0.40) HPGDALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL5508948 0.83 POLB (0.44) ALDH1A1MAPTL3MBTL1LMNAMEN1
SCHEMBL5513494 0.74 POLB (0.41) ALDH1A1MAPTLMNAMEN1KMT2A
SCHEMBL5509910 0.74 MAPT (0.36) HPGDALDH1A1MAPTL3MBTL1LMNA
SCHEMBL16704191 0.73 HPGD (0.56) HPGDALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL5511798 0.71 HTT (0.44) ALDH1A1MAPTKDM4EL3MBTL1LMNA
SCHEMBL11818104 0.71 HPGD (0.60) HPGDALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL8372369 0.69 HPGD (0.61) HPGDALDH1A1MAPTKDM4ELMNA
SCHEMBL2945030 0.69 HPGD (0.53) HPGDALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL12768203 0.68 TSHR (0.38) ALDH1A1LMNAPKMTSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205296-B2 Substituted 2H-1,3-benzoxazin-4(3H)-ones PORTOLA PHARMACEUTICALS, INC. (US) 2007-04-17 US disclosed
US-7205296-B2 Substituted 2H-1,3-benzoxazin-4(3H)-ones PORTOLA PHARMACEUTICALS, INC. (US) 2007-04-17 US disclosed
US-7205296-B2 Substituted 2H-1,3-benzoxazin-4(3H)-ones PORTOLA PHARMACEUTICALS, INC. (US) 2007-04-17 US disclosed
US-20060069093-A1 Substituted 2H-1,3-benzoxazin-4(3H)-ones PORTOLA PHARMACEUTICALS, INC. (US) 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069093-A1 Substituted 2H-1,3-benzoxazin-4(3H)-ones TBXAS1, TBXA2R, SERPINC1 HPGD 216/4885ALDH1A1 704/4885MAPT 4809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.